One Stage Ridge Splitting Using 2 Different Techniques in Maxilla
* The selected patients will be informed of the nature of the research work and informed consent will be obtained. * Patients of both groups will be subjected to CBCT. * Intra operative procedures (for both groups) followed by CBCT will be taken for every patient after 4 months. * Infiltration local anesthesia will be
| Condition(s) | Ridge Augmentation, Bone Augmentation |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | * The selected patients will be informed of the nature of the research work and informed consent will be obtained. * Patients of both groups will be subjected to CBCT. * Intra operative procedures (for both groups) followed by CBCT will be taken for every patient after 4 months. * Infiltration local anesthesia will be given to the patient (Articaine 4% 1:100 000 epinephrine) Both the study and control group will receive: * In Recipient site, full thickness mucoperiosteal flap pyramidal flap, reflection using mucoperiosteal elevator. * The defective site is reevaluated. * Flap advancement inorder to allow tension free flap closure. * In the Study group: Piezo surgery bone inserts is used to cut crestal osteotomies. * In the Control group: Bone discs diameter is used. * Followed by, the use |
| Who can participate | Inclusion Criteria: * Patients with maxilla residual alveolar bone height not less than 8 mm. * Alveolar bone width from 5mm to 3mm. * Both genders. * At least single missing tooth. * Previous failed implants. * Tapered or cylinder cross sectioned alveolar bone defect pattern. Exclusion Criteria: * Heavy smokers more than 20 cigarettes per day. * Patients with bone disease that may affect normal healing, example; hyperparathyroidism. * Patients had radiotherapy and chemotherapy in head and neck. * Patients had neoplasms in sites to be grafted. * Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl. * Pregnant females. * Patients with Para functional habits, apprehensive and non-cooperative. * Bone pathology related to the site to |
| Ages | 20 Years to 48 Years |
| Sex | All |
| Lead sponsor | Cairo University |
| Locations | Cairo, Egypt |
| Start date | 2025-02-26 |
| NCT ID | NCT06891261 |
| Official listing | https://clinicaltrials.gov/study/NCT06891261 |